J&J is in discussions to buy out Protagonist Therapeutics — reportnews2025-10-10T17:04:46+00:00October 10th, 2025|Endpoints News|
Bristol Myers joins in vivo CAR-T race with $1.5B Orbital acquisitionnews2025-10-10T11:28:23+00:00October 10th, 2025|Endpoints News|
Otsuka Precision Health buys maternal meditation platform Mindful Mamasnews2025-10-09T13:32:57+00:00October 9th, 2025|Endpoints News|
Updated: Novo Nordisk to buy MASH player Akero for $4.7B upfrontnews2025-10-09T10:23:59+00:00October 9th, 2025|Endpoints News|
In $2B biobucks pact, Zenas snags MS drug that Biogen returned to InnoCarenews2025-10-08T11:24:07+00:00October 8th, 2025|Endpoints News|
Metsera got less than it wanted from Pfizer in long-awaited obesity biotech acquisitionnews2025-10-06T11:41:42+00:00October 6th, 2025|Endpoints News|
Arbor partners with Chiesi Group in gene editing dealnews2025-10-06T11:00:11+00:00October 6th, 2025|Endpoints News|
Roche was the only pharma to make an acquisition offer for 89bionews2025-10-02T12:41:57+00:00October 2nd, 2025|Endpoints News|
Galapagos says it’s weeks away from decision on cell therapy business reviewnews2025-10-02T01:59:11+00:00October 2nd, 2025|Endpoints News|
Halozyme to spend $750M upfront to buy Elektrofi, a biologics tech delivery companynews2025-10-01T14:43:46+00:00October 1st, 2025|Endpoints News|
